DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 90 pce

7680668750030 CH-66875 G04CA52 05.99.0.
DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 90 pce
DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 90 pce
DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 90 pce
1 / 3
google

Details

Product number
6687501
CPT
-
Packaging group
90
Unit
Kapsel(n)
Composition
dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, propylenglycoli monocaprylas corresp. propylenglycolum 112.65 mg, E 321, gelatina, glycerolum, E 171, triglycerida media, lecithinum ex soja, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (nigrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.

Articles (1)

Dutasterid Duo Spirig HC 0.5 mg/0.4 mg, Hartkapseln
Kapseln
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/04/2025
Patient information leaflet
Français
29/04/2025
Patient information leaflet
Italien
29/04/2025
Professional SmPC
Allemand
29/04/2025
Professional SmPC
Français
29/04/2025
Professional SmPC
Italien
29/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
0.4 MG Substance Wirkstoff (Principe actif)
(N/A)
0.367 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
112.65 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.09 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 67.85
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2019

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
66875
Drug name
Dutasterid Duo Spirig HC, Hartkapseln
Galenic form
KAHA
ATC Code
G04CA52
Authorization status
Z
Dispensation category
B
First authorization
24/09/2018
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
Benigne Prostatahyperplasie

Packaging details

Description (FR)
DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 90 pce
Description (DE)
DUTASTERID DUO Spirig HC Kaps 0.5mg/0.4mg 90 Stk
Market launch
24/09/2018
Narcotic (BTM)
No

Original drug

Duodart, Hartkapseln
CHF 49.90
View original

Other packaging sizes

DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 7 pce
7 KAP
View
DUTASTERIDE DUO Spirig HC caps 0.5mg/0.4mg 30 pce
30 KAP
View